AbbVie Just Paid $10.9 Billion For This Tiny Biotech. Here’s Why.
Apogee Therapeutics went to bed Friday at about $90 a share. It woke up Monday worth $132 and change. By Tuesday, most analysts had stopped… Read More »AbbVie Just Paid $10.9 Billion For This Tiny Biotech. Here’s Why.









